CWA
ONCT

CM Wealth Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

CM Wealth Advisors’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,782
Closed -$16K – 457
2023
Q1 		$16K Buy
+2,782
New +$54.8K ﹤0.01% 414

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CM Wealth Advisors's ONCT Position: Q2 2023 in Review

CM Wealth Advisors sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2023, closing a stake of 2,782 shares — an estimated $16K sold.

CM Wealth Advisors first reported a position in ONCT in Q1 2023 and held it in 1 quarter. The position peaked at $16K in Q1 2023. 52 funds tracked by Wall St. Rank hold ONCT as of Q2 2023.

  • CM Wealth Advisors reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • CM Wealth Advisors sold 2,782 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $16K.
  • CM Wealth Advisors first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • CM Wealth Advisors's Oncternal Therapeutics, Inc. Common Stock position peaked at $16K in Q1 2023.
  • 52 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2023.

Based on CM Wealth Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.